Sophia Genetics SA (SOPH) Actualités

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results PR Newswire BOSTON and ROLLE, Switzerland...

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing PR Newswire BOSTON, MA and ROLLE...

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing PR Newswire BOSTON, MA and ROLLE...

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025 PR...

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities PR Newswire BOSTON, MA and ROLLE...

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities PR Newswire BOSTON, MA and ROLLE...

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities